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Introduction: Eosinophilic esophagitis was first reported in 1978, and since then it has been increasingly
recognized as one of the major etiologies for dysphagia, food impaction, and food regurgitation. To the best of our
knowledge, no case of eosinophilic esophagitis (excluding esophageal eosinophilia not responsive to proton pump
inhibitor treatment) has previously been demonstrated on the basis of positron emission tomography imaging.
Case presentation: A 68-year-old Caucasian man presented with dysphagia to solids with recurrent regurgitation
and weight loss of 7lb within the preceding 2 months. The patient attributed these symptoms to radiation therapy
he had received 1 year earlier for squamous cell cancer of the lung. The patient underwent routine follow-up
positron emission tomography imaging, which showed a hypermetabolic lesion in the posterior mediastinum and
was increased at the level of the midesophagus.
Conclusion: To the best of our knowledge, this is the first reported case of eosinophilic esophagitis demonstrated
by positron emission tomography imaging and confirmed with endoscopic evaluation and biopsies both after
positron emission tomography imaging and a trial of proton pump inhibitor therapy. This could have an impact on
the diagnostic evaluation of esophageal eosinophilic inflammation as well as eosinophilic infiltration of other
gastrointestinal organs.Introduction
Eosinophilic esophagitis (EoE) was first reported by
Landres et al. in 1978, and since then it has been
increasingly recognized as one of the major etiologies
for dysphagia, food impaction, and food regurgitation
[1]. Its prevalence is estimated to be 0.4% in an asymp-
tomatic adult population [2]. Among patients undergo-
ing outpatient upper endoscopy for any indication, the
prevalence of EoE varies between 5% to 16% and is
highest in patients with dysphagia [3]. The proposed
diagnostic criteria for EoE includes more than 15 eosino-
phils per high-power field (HPF) in the esophageal
epithelium. Although the true pathophysiology of EoE
remains unknown, the literature has attributed the main
etiology of EoE to allergic and genetic causes [4].* Correspondence: ron-schey@uiowa.edu
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A 68-year-old Caucasian man with a history of squa-
mous cell cancer of the lung in 2011 and a remote his-
tory of T4aN2cM0 squamous cell carcinoma of the right
oropharynx was referred to our institution because of
progressive dysphagia to solids with recurrent regurgita-
tion and loss of 7lb within the previous 2 months. The
patient attributed the symptoms to radiation therapy he
had received following chemotherapy in late 2011. The
patient had done well for more than 1 year and had been
followed by primary care and oncology clinicians. Given
the worry for malignancy as a cause of his dysphagia, he
underwent follow-up positron emission tomography-
computed tomography (PET-CT) imaging. This showed
a hypermetabolic lesion (standardized uptake value 7.6)
in the posterior mediastinum increased in the level of
midesophagus, as shown in both the axial and sagittal
positions (Figures 1 and 2). His physical examination did
not reveal any oral thrush or palpable lymphadenopathy.
He had no history of allergic disease or atopy. AnLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Sagittal positron emission tomography-computed
tomography imaging demonstrating a hypermetabolic lesion in
the posterior mediastinum with increased levels in
the midesophagus.
Figure 3 Midesophageal biopsies revealing significant
eosinophilia of the midesophagus, with 80 eosinophils per
high-power field and associated parakeratosis consistent with
eosinophilic esophagitis.
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revealed esophageal rings and linear furrowing in the
midesophagus without evidence of acid reflux disease. Bi-
opsies from the distal, middle, and proximal esophagus
were taken, which revealed significant eosinophilia of the
midesophagus with up to 80 eosinophils per HPF and as-
sociated parakeratosis consistent with EoE (Figure 3). We
elected to perform empiric dilation, and the patient was
treated with omeprazole 20mg bid, which led to mild im-
provement in symptoms but also an episode of food bolus
impaction 6 weeks after initiation of treatment. An emer-
gency EGD revealed the same findings, with biopsies
showing more than 30 eosinophils per HPF. Swallowed
fluticasone 440μg bid was added to the patient’s treatment
protocol, which led to a good response. Unfortunately, 8
weeks after treatment the patient died suddenly due to a
cerebrovascular accident.Figure 2 Axial positron emission tomography-computed
tomography image demonstrating increased uptake in
the midesophagus.Conclusions
Although weight loss is not a common presenting symp-
tom of patients with EoE, we believe that, due to weight
gain along with alleviation of symptoms after induction of
the combined treatment, it would be reasonable to assume
that this was the cause of weight loss in our patient.
To the best of our knowledge, there is only one other re-
port of EoE demonstrated by PET imaging and confirmed
with endoscopic evaluation and biopsies [5]. However, that
report did not comment on proton pump inhibitor ther-
apy (PPI) or other treatment prior to or at the time of
follow-up after the PET scan. Therefore, it did not exclude
PPI-responsive esophageal eosinophilia (PPI-REE).
In our patient, there was intense eosinophilia of the
affected area of the midesophagus, with up to 80 eosino-
phils per HPF with repeat biopsies after 6wk of treat-
ment showing more than 30 eosinophils per HPF. His
history of long-term symptoms of dysphagia, which be-
came more progressive, are typical of patients presenting
with EoE. Previous reports have described CT findings
of thickening of the esophagus related to EoE [6]. It is
likely that other inflammatory conditions of the esopha-
gus would show similar results and could include infec-
tious esophagitis, reflux esophagitis, malignancy, and
others. Given the cost associated with PET-CT imaging
and the broad differential of positive findings, we do not
suggest that this modality has a primary role in diagnos-
ing EoE at this time. However, it can potentially provide
another diagnostic modality besides upper endoscopy. It
may also provide information which could distinguish
between PPI-REE and EoE, which could affect treatment
decisions. More studies need to be done in this area, but
in our patient the PET imaging demonstrated intense
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did not respond to PPI treatment.
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